- ISIN
- US30205M1018
- CUSIP
- 30205M101
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- May 22, 2018
Highlights
- Market Cap
- $20.14M
- Enterprise Value
- $17.54M
- EPS (TTM)
- -$1.55
- Gross Profit (TTM)
- -$157.00K
- EBITDA (TTM)
- -$8.38M
- Year Range
- $2.63 - $10.80
- Target Price
- $12.00
- ROA (TTM)
- -76.71%
- ROE (TTM)
- -466.35%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
XCUR Performance Chart
Exicure, Inc. (XCUR) is down 41.7% since the beginning of the year. At $3 per share, XCUR is trading 70.7% below its 52-week high of $11. Investors who bought $1,000 worth of XCUR shares 5 years ago would now be looking at an investment worth $13.
Loading charts...
Returns By Period
Exicure, Inc. (XCUR) has returned -41.70% so far this year and -69.53% over the past 12 months.
Exicure, Inc.
- 1D
- 1.61%
- 1M
- -2.77%
- YTD
- -41.70%
- 6M
- -43.17%
- 1Y
- -69.53%
- 3Y*
- -11.11%
- 5Y*
- -58.30%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
XCUR Monthly Returns History
Based on dividend-adjusted daily data since May 22, 2018, XCUR's average daily return is +0.06%, while the average monthly return is +4.43%. At this rate, an investment would double in approximately 1.3 years.
Historically, 34% of months were positive and 66% were negative. The best month was Nov 2024 with a return of +873.3%, while the worst month was Nov 2021 at -58.5%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.
On a daily basis, XCUR closed higher 41% of trading days. The best single day was Nov 20, 2024 with a return of +92.3%, while the worst single day was Dec 13, 2021 at -40.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -24.91% | -8.11% | 13.76% | -21.02% | -5.06% | -0.94% | -41.70% | ||||||
| 2025 | -17.85% | -15.85% | 41.16% | -21.66% | -5.55% | -28.67% | 1.28% | -21.32% | -27.09% | 7.58% | -5.00% | 29.67% | -60.35% |
| 2024 | -6.87% | 31.39% | -15.29% | -14.21% | -13.91% | -27.96% | 36.91% | -10.07% | 76.14% | -12.68% | 873.27% | -53.65% | 371.14% |
| 2023 | 22.61% | -17.73% | -24.91% | 12.40% | -10.01% | 48.69% | -21.37% | -11.65% | -20.88% | -12.50% | -26.83% | 25.88% | -49.54% |
| 2022 | -1.63% | 0.75% | -0.40% | -29.82% | -4.29% | -46.27% | -25.00% | 12.96% | -14.21% | -8.92% | -30.07% | 15.00% | -81.03% |
| 2021 | 20.34% | 1.88% | 0.46% | -9.63% | -15.23% | -10.18% | -10.00% | 3.70% | -14.29% | -5.83% | -58.50% | -56.90% | -88.58% |
Benchmark Metrics
Exicure, Inc. has an annualized alpha of 4.05%, beta of 0.80, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since May 23, 2018.
- This stock participated in 189.28% of S&P 500 Index downside but only -31.05% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 4.05%
- Beta
- 0.80
- R²
- 0.01
- Upside Capture
- -31.05%
- Downside Capture
- 189.28%
Return for Risk
Risk / Return Rank
XCUR ranks 12 for risk / return — in the bottom 12% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Exicure, Inc. (XCUR) and compare them to S&P 500 Index.
| XCUR | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.62 | 2.24 | -2.86 |
Sortino ratioReturn per unit of downside risk | -0.78 | 3.07 | -3.85 |
Omega ratioGain probability vs. loss probability | 0.91 | 1.41 | -0.50 |
Calmar ratioReturn relative to maximum drawdown | -0.93 | 2.93 | -3.85 |
Martin ratioReturn relative to average drawdown | -1.27 | 13.52 | -14.79 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Exicure, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Exicure, Inc. was 99.85%, occurring on Jul 9, 2024. The portfolio has not yet recovered.
The current Exicure, Inc. drawdown is 99.68%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -99.85%Jul 2024 | 5y 9mo | — | 7y 8moSep 2018 - now |
2018 bear market2018 | -20.67%Aug 2018 | 1mo 5d | 1mo 18d | 2mo 23dJun 2018 - Sep 2018 |
2018 pullback2018 | -9.18%May 2018 | 1d | 12d | 13dMay 2018 - Jun 2018 |
2018 pullback2018 | -6.67%Jun 2018 | 0s | 3d | 3dJun 2018 - Jun 2018 |
2018 pullback2018 | -2.49%Jun 2018 | 1d | 4d | 5dJun 2018 - Jun 2018 |
Drawdown Indicators
| XCUR | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.85% | -56.78% | -43.07% |
Max Drawdown (1Y)Largest decline over 1 year | -75.24% | -9.10% | -66.14% |
Max Drawdown (3Y)Largest decline over 3 years | -91.64% | -18.90% | -72.74% |
Max Drawdown (5Y)Largest decline over 5 years | -99.45% | -25.43% | -74.02% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.68% | -0.74% | -98.94% |
Average DrawdownAverage peak-to-trough decline | -81.64% | -10.72% | -70.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.93% | 1.97% | +52.96% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Exicure, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Exicure, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for XCUR in comparison with other companies in the Biotechnology industry. Currently, XCUR has a P/B value of 9.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with XCUR
Add Exicure, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with XCUR